SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-018189
Filing Date
2020-04-23
Accepted
2020-04-23 16:05:40
Documents
6
Period of Report
2020-06-04
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A fgen-def14a_20200604.htm DEF 14A 2535534
2 GRAPHIC gbzbbkelopp4000002.jpg GRAPHIC 5391
3 GRAPHIC gbzbbkelopp4000004.jpg GRAPHIC 67252
4 GRAPHIC gbzbbkelopp4000003.jpg GRAPHIC 5575
5 GRAPHIC gbzbbkelopp4000005.jpg GRAPHIC 67261
6 GRAPHIC gbzbbkelopp4000001.jpg GRAPHIC 5852
  Complete submission text file 0001564590-20-018189.txt   2745683
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36740 | Film No.: 20811062
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences